{"name": "Intercell",
 "permalink": "intercell-biomedical-research-development-ag",
 "crunchbase_url": "http://www.crunchbase.com/company/intercell-biomedical-research-development-ag",
 "homepage_url": "http://www.intercell.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 403,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@intercell.com",
 "phone_number": "+43-1-20620",
 "description": "",
 "created_at": "Thu Sep 10 01:58:13 UTC 2009",
 "updated_at": "Sat May 07 02:36:18 UTC 2011",
 "overview": "\u003Cp\u003EIntercell AG, a biotechnology company, engages in the design and development of vaccines for the prevention and treatment of infectious diseases. It discovers and develops antigens and adjuvants, which are derived from its proprietary technology platforms. \u003C/p\u003E\n\n\u003Cp\u003EThe company was founded in 1998 and is headquartered in Vienna, Austria.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       147],
      "assets/images/resized/0005/9315/59315v1-max-150x150.jpg"],
     [[175,
       172],
      "assets/images/resized/0005/9315/59315v1-max-250x250.jpg"],
     [[175,
       172],
      "assets/images/resized/0005/9315/59315v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Thomas",
      "last_name": "Lingelbach",
      "permalink": "thomas-lingelbach-2",
      "image": null}},
   {"is_past": false,
    "title": "Site Director",
    "person":
     {"first_name": "Eric",
      "last_name": "Frings",
      "permalink": "eric-frings",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [{"price_amount": 186460000.0,
    "price_currency_code": "USD",
    "term_code": null,
    "source_url": "",
    "source_description": "Cap Funding Report",
    "acquired_year": 2008,
    "acquired_month": 5,
    "acquired_day": 12,
    "company":
     {"name": "Iomai Corporation",
      "permalink": "iomai",
      "image":
       {"available_sizes":
         [[[150,
            55],
           "assets/images/resized/0005/9314/59314v2-max-150x150.jpg"],
          [[250,
            92],
           "assets/images/resized/0005/9314/59314v2-max-250x250.jpg"],
          [[253,
            94],
           "assets/images/resized/0005/9314/59314v2-max-450x450.jpg"]],
        "attribution": null}}}],
 "offices":
  [{"description": "",
    "address1": "Campus Vienna Biocenter 6",
    "address2": "",
    "zip_code": "1030",
    "city": "Vienna",
    "state_code": null,
    "country_code": "AUT",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}